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ABSTRACT
Cognitive Function Following Bubble-Contrast Transcranial Doppler
for Evaluation of Right-to-Left Shunt
Erin E. Krauskopf
Department of Psychology, BYU
Doctor of Philosophy
Background: Stroke is a leading cause of significant physical, cognitive, and psychiatric
morbidity. One risk factor for stroke is paradoxical embolization through a patent foramen ovale
(PFO). In cardiac clinical practice, power M-mode Transcranial Doppler (TCD) evaluation is the
gold standard for diagnosis of PFO, or right-to-left cardiac shunt (RLS). Brain microembolization due to diagnostic bubble contrast echocardiography may cause neurological
symptoms in patients with PFO. However, the neurocognitive effects of TCD have not been
studied. Objective: The purpose of this study was to evaluate cognitive outcomes in patients who
undergo routine diagnostic bubble contrast TCD. The aims of the study were (1) to determine if
cognitive function declines pre- to post-TCD evaluation and, (2) to assess the relationship
between cognitive function and severity of the RLS measured using the Spencer Grading
System. Methods: One hundred and four participants referred to Sorensen Cardiovascular Group
for diagnosis of RLS were evaluated for changes in cognitive functioning at three time points. A
dual baseline (pre-test and baseline test) was administered to mitigate practice effects between
the first and second administrations. All pre and post-TCD comparisons were analyzed using the
baseline test and post-TCD test, controlling for the effects of practice, if present. Results:
Practice effects were observed for the working memory task, with significant improvement in
working memory scores occurring between the first (pre-test) and second (baseline)
administrations. The main effect for shunt group (no shunt vs. moderate-to-severe shunt) and the
shunt group by time interactions were not significant for processing speed, attention, or working
memory, adjusting for practice effects, age, and education. Migraine did not predict group status
for mood or shunt variables. Conclusion: Cardiac patients with both small and large RLS did not
experience a decline in processing speed, attention, or working memory ability following TCD,
suggesting that TCD-induced microemboli do not result in immediate cognitive deficits in these
domains. These findings support the use of TCD for routine evaluation of PFO, even in patients
with severe RLS, although findings are limited to young (30s), medically healthy, predominately
Caucasian individuals assessed immediately following TCD. Results do not exclude the
possibility of cognitive impairment at follow-up, on other cognitive tests, or in other cognitive
domains.
Keywords: patent foramen ovale (PFO), cryptogenic stroke, right-to-left shunt (RLS), cerebral
vascular accident (CVA), transcranial Doppler ultrasound (TCD), migraine, cognition
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Cognitive Function Following Bubble-Contrast Transcranial Doppler
for Evaluation of Right-to-Left Shunt
In the United States, approximately 800,000 people suffer a new or recurrent stroke each
year and stroke remains a leading cause of disability and morbidity, accounting for 144,000
deaths in 2005 (Lloyd-Jones et al., 2009). Neurologic disability following cerebral vascular
accident (CVA) is one of the greatest fears of patients and their families due to the resulting
impaired cognitive function and physical disability, which is often described as worse than death
(Solomon, Glick, Russo, Lee, & Schulman, 1994). Stroke also represents an important personal
and public health problem due to the cost of care associated with poor physical, psychiatric,
cognitive, and functional outcomes. Ischemic stroke affects 15 million people per year (Mackay
& Mensah, 2004) and the estimated lifetime economic burden was $90,981 per person in 1996
(Taylor et al., 1996) and is likely considerably higher today. Recognition of the permanence and
non-reversibility of stroke, the associated cognitive and physical morbidities, and the economic
burden has prompted a shift from post-CVA treatment to early diagnosis and preventative
strategies by medical professionals.
Neurological morbidities associated with CVA include cognitive dysfunction, psychiatric
disorders, including depression and anxiety (Gas & Lawhorn, 1991), and reduced quality of life.
During the acute stages post-stroke 35-60% of patients experience depression, at two years
depression persists in 57% of survivors (Bour, Rasquin, Limburg, & Verhey, 2011; Parikh,
Lipsey, Robinson, & Price, 1987; Paolucci, 2008) and 28% of survivors meet criteria for
generalized anxiety disorder (GAD). Prevalence of depression post-stroke does not differ
between men and women and an estimated 26% of men and 39% of women may also experience
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comorbid anxiety (Burvill et al., 1995). Depression in stroke patients predicts cognitive decline
including deficits in memory, attention, problem solving, and mental speed (Kauhanen et al.,
1999), development of dementia (Butters et al., 2000; Li et al., 2001), and poor response to
depressive medication (Bour et al., 2011). Psychiatric and cognitive symptoms co-occur in an
estimated 22% of patients one month post-stroke (Bour et al., 2011), although there are subsets
of patients who experience either psychiatric or cognitive deficits alone. Many studies have
demonstrated the dynamic interplay between psychiatric and cognitive symptoms including a
bidirectional relationship between depression and executive dysfunction (Mast, Yochim,
MacNeill, & Lichtenberg, 2004; Nys et al., 2005), which may result from damage to shared
neuroanatomical pathways, such as frontal-subcortical networks (Alexopoulos, Kiosses,
Klimstra, Kalayam, & Bruce, 2002; Verdelho, Henon, Lebert, Pasquier, & Leys, 2004). Indeed,
lesion characteristics predict depression and anxiety post-stroke, with associations between GAD
and right hemispheric lesions and comorbid GAD and depression with left hemispheric
involvement (Astrom, 1996). Although cognitive deficits following CVA may also depend on
the brain regions affected, common deficits include impaired orientation, problem solving
(Weimar et al., 2002), executive functioning (Bour et al., 2011), visuo-perception, language (Nys
et al., 2007), memory, and slowed psychomotor speed (Jurate, Krisciunas, & Endezelyte, 2008).
Post-stroke psychiatric and cognitive disorders significantly interfere with patients’ ability to
carry out activities of daily living (Popovich, Fox, & Bandagi, 2007) disrupt social networks and
social support (Astrom, 1996) and contribute to poor functional outcome (Freed & Wainapel,
1983; Hermann, Black, Lawrence, Szekely, & Szalai, 1998; Khedr et al., 2009).
The etiologies of CVA are heterogeneous and thus require different prophylactic and
interventional strategies. Hemorrhagic strokes may result from anti-coagulant medications,
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vascular malformations, including ruptured aneurysms or arterial-venous malformations
(AVMs), or neurotrauma, and are often unpredictable. Ischemic strokes, which account for
roughly 87% of all strokes annually (Akhondi et al., 2010), may result from pulmonary or
cardiac emboli, large or small artery thrombi, or atherosclerosis due to long-standing vascular
risk factors (diabetes, hypertension, hyperlipidemia). Prevention of ischemic stroke includes
cardiovascular management through exercise, magnetic resonance angiography, pharmacological
treatment, and prevention of paradoxical embolization. Paradoxical embolization occurs when a
venous emboli reaches the arterial circulation through a low-pressure right-to-left shunt (RLS),
such as a patient foramen ovale (PFO), as the venous blood has bypassed the pulmonary filter
(Kondapaneni, 2004). Paradoxical embolization is relatively common and may be associated
with transient ischemic attacks, stroke, decompression disorders, air and fat embolization,
migraine headache, and hypoxemia (Hara et al., 2005). Individuals with large and continuous
RLS, such as those with a PFO have a higher risk of such adverse events. In healthy adults, RLS
is often asymptomatic and may go unrecognized until paradoxical embolization occurs.
Patent Foramen Ovale
In utero, the septum premium and septum secondum act as a dynamic tunnel (foramen
ovale) that enables maternal oxygenated blood to pass directly through the inferior vena cava,
bypassing the unaerated fetal lungs (Latson, 2007; Moore & Persaud, 2003; Thomas, Bynevelt,
& Price, 2005). Within two years after birth, increased pulmonary vascular resistance and
pressure in the left atrium causes the foramen ovale to permanently fuse in 70-75% of
individuals, creating the atrial septum which separates the right and left atria of the heart
(Thomas et al., 2005). This allows venous (deoxygenated) blood to be filtered by the lungs prior
to traveling through the arterial (oxygenated) circulation to the brain (Drighil, Mosalami,
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Elbadoui, Chraibi, & Bennis, 2007; Ning et al., 2013). In approximately 20-30% of the adult
population the septum does not close, resulting in a PFO (Figures 1 & 2) which permits interatrial blood flow when pulmonary pressure increases, such as during Valsalva maneuver, cough,
or sexual intercourse (Drighil et al., 2007; Thomas et al., 2005). When pulmonary pressure
increases the right atrial pressure exceeds the left and the septum flap opens, allowing dynamic
right-to-left blood flow. A PFO accounts for 95% of all RLS (Sathasivam and Sathasivam,
2013), and thus acts as a conduit for paradoxical embolism and potential subsequent stroke due
to the passage of thromboemboli through the cerebral arteries to the brain. Indeed, PFO-related
strokes affect more than 150,000 people per year in the US and are diagnosed in 40% of patients
with cryptogenic stroke and 60% of patients with migraine with aura (Drighil et al., 2007; Hara
et al., 2005; Ning et al., 2013). A PFO can also cause non-cerebral, paradoxical systemic events
such as coronary artery embolism leading to myocardial infarction (MI), renal infarction, or limb
ischemia (Agarwal & Kapadia, 2010; Fazio, 2010; Iwasaki et al., 2011; Ramineni & Daniel,
2010).
Individuals with a PFO are often asymptomatic and unaware of their arterial
malformation, unless it is coupled with an atrial septal aneurysm (ASA), which increases the
severity of the shunt and is more likely to lead to neurologic symptoms or stroke (Ning et al.,
2013). Epidemiological studies of PFO are lacking, making it difficult to predict phenotypic
characteristics of PFOs. Prevalence of PFO in the adult population is approximately 25-30%, is
equally likely in men and women, and prevalence decreases with age, occurring in 20% in
individuals who are greater than 80 years old (Cruz-Gonzalez, Solis, Inglessis-Aziaje, &
Palacios, 2008). The small difference in prevalence may reflect the fact that individuals with a
PFO are more likely to experience a CVA at younger age and have higher rates of mortality.
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Interestingly, the size of the PFO (range of 1 to 19mm) increases with age; in the first 10 years of
life mean diameter is 3.4mm compared to a mean diameter of 5.8mm in individuals over 90
years of age (Hagen, Scholz, & Edwards, 1984; Cruz-Gonzalez et al., 2008). Although a larger
PFO resulting in greater RLS is more likely in older individuals, large PFOs occur in younger
individuals as well. The absence of epidemiological information in individuals with PFOs makes
it difficult to predict who will have a PFO prior to the occurrence of stroke.
Patent Foramen Ovale and Stroke
In approximately 40% of individuals the pathogenesis of the stroke cannot be attributed
to a specific etiology (e.g. cryptogenic) (Di Tullio, Sacco, Gopal, Mohr, & Homma, 1992;
Halperin & Fuster, 2002). Strokes in individuals younger than 60 years of age may be due to
arterial septal aneurysm (left-to-right-shunt), atrial fibrillation (Lamy et al., 2002), or PFO. The
presence of PFO in younger (aged <55) patients with cryptogenic stroke is estimated at 30-77%
and is significantly higher than in patients who have a CVA with an identifiable etiology (Di
Tullio et al., 1992; Hagen et al., 1984; Lechat et al., 1988; Mas et al., 2001), suggesting that PFO
may be a significant risk factor for CVA in low-risk populations (Bogousslavsky, Garazi,
Jeanrenaud, Aebischer, & Van Melle, 1996; Lamy et al., 2002; Zito et al., 2009). The severity of
the shunt and size of the PFO are associated with paradoxical embolism in patients who have
unexplained CVAs (Hausmann, Mugge, & Daniel, 1995; Homma et al., 1994), although no
differences in embolic features have been detected between individuals with large compared to
small shunts (Lamy et al., 2002). Valsalva maneuver preceding stroke onset has been reported in
PFO-related stroke, with higher incidence in men (>15%) (Langholz, Louie, Konstadt, Rao, &
Scanlon, 1991; Ning et al., 2008). A PFO increases the risk of stroke in older individuals as
well, especially in the context of critical illness and venous clotting (Handke, Harloff,
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Olschewski, Hetzel, & Geibel, 2007; Jacobs, Boden-Albala, Lin, & Sacco, 2002; Petrea et al.,
2011; Schneider et al., 2004). Clinical outcomes in PFO patients with stroke and or transient
ischemic attacks include unilateral sensory deficits, hemiplegia, hemianopsia, and hearing loss
(Komar et al., 2012).
Mechanisms of Ischemic Stroke
Cerebral ischemia reduces oxygen and glucose supply to brain tissue and initiates
destructive cellular and molecular mechanisms that impair energy resources required to maintain
ionic gradients in the brain. The mechanisms include a series of pathophysiological events, such
as cellular depolarization and calcium influx, resulting in excitotoxic cell death, that depend on
the duration, severity, and location of the focal ischemic event (Traystman, 2003). Ischemic
stroke occurs following a diminution of cerebral blood flow (CBF) to a critical threshold and
ischemic polarization occurs when CBF decreases to levels of approximately 18 mL/100g of
brain tissue per minute, while apoptosis and necrosis occur if flow reduces to 10 mL/100g or less
(Harukuni & Bhardwaj, 2006). Normal CBF ranges from 50 to 75mL/100g of brain tissue per
minute and differs between gray and white matter due to cell density.
Focal ischemia is a reduction in blood flow to a very distinct brain region in which no
blood flow is found at the core of the event, called the ischemic core. Distal regions of the event
are marginally perfused where flow reaches the edges of the affected area via collateral
circulation, called the ischemic penumbra (Harukuni & Bhardwaj, 2006). In multifocal ischemia
or hypoxia, such as paradoxical cardiac embolism, or hypothetically microembolisation during
TCD, there is a patchy pattern of reduced CBF in the middle cerebral artery. This typically
affects cortical and striatal regions, although the degree and distribution of flow depends on the
degree and duration of the occlusion, site along the middle cerebral artery and the amount of
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collateral flow (arising from posterior communicating arteries) into its territory (Traystman et al.,
2003; Wholey & El-Merhi, 2011). Striatal (caudate and putamen) and basal ganglia infarcts are
most commonly observed following middle cerebral artery occlusion and are thought to be
selectively vulnerable due to changes in catecholamine release and metabolism (Harukuni &
Bhardwaj, 2006). Damage to these regions result in facial and upper arm weakness in baboons
(Symon, Pasztor, & Branston, 1974; Weinstein, Anderson, & Telles, 1986) and impaired
learning and memory (Hattori et al., 2000) and altered level of alertness in the rat (Block, 1991).
Hattori et al. (2000) observed no cognitive impairment after 60 minutes, impaired learning and
memory after 90 minutes, and permanently impaired sensory motor function (skilled motor
activity and sensorimotor control) after 120 minutes of middle cerebral artery occlusion,
suggesting that lengthy periods of reduced flow are necessary to produce neurological effects, at
least in rodents. Other animal models have demonstrated that shorter duration of ischemic
events does not produce lasting deficits. Matsui and Kumagae (1991) found that 15 minutes of
global ischemia in dogs resulted in permanent cognitive impairments, while 10 minutes of global
ischemia did not produce lasting effects. Cipolla, Lessov, Hammer, and Curry (2001)
demonstrated that vascular tone in the middle cerebral arteries, an indirect measure of blood
perfusion and ischemia, is similar between rats exposed to 15 minutes of ischemia and controls,
while significantly reduced tone occurs only after 30-120 minutes (Cipolla et al., 2001). Block
(1999) reported that one hour of ischemia results in a 50% reduction in motor functioning in rats
(grasping, reflexes, equilibrium) that resolved at 24, 48, and 72 hours. These studies suggest that
reductions in blood flow to the middle cerebral arteries of short duration may not result in
permanent cognitive effects and that duration and degree of blood flow obstruction are important
predictors of impairment in ischemic stroke.
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Neural Effects of Patent Foramen Ovale
Individuals with PFOs may develop abnormalities on neuroimaging, with brain lesions
occurring in multiple regions (Bonati et al., 2006; Jauss, Wessels, Trittmacher, Allendorfer, &
Kaps, 2006) including single non-territorial infarcts (in both cortical and subcortical regions),
territorial infarcts, multiple ischemic lesions in the area of the posterior circulation, and
peripheral arterial ischemia (renal, axillary, and femoral arteries) (Bonati et al., 2006; Clergeau et
al., 2009; Jauss et al., 2006). Ischemic changes are typically found in both the periventricular
and deep white matter regions (Adami et al., 2008). High intensity transient signals have been
found in middle cerebral and basilar artery regions following stroke and TIA in PFO patients,
with significant associations between distribution of air bubbles and clinical symptoms (Telman,
Kouperberg, Sprecher, Goldsher, & Yarnitsky, 2005). Interestingly, in individuals with migraine
who have prolonged visual-motor aura, reversible cortical abnormalities found on DWI and
FLAIR sequences have been described and are thought to be the expression of vasogenic edema
(Resnick, Reyes-Iglesias, Carreras, & Villalobos, 2006). Abnormalities on neuroimaging
suggest that at least in some cases the presence of a PFO represents a serious risk for
neurological injury, although transient effects may also be possible.
Pathological Manifestations of Patent Foramen Ovale
In addition to stroke and paradoxical embolism, an increasing number of medical
conditions associated with PFO have been identified. PFO may play a causative role or may be
an associated condition predisposing the patient to additional complications including platypnea–
orthodeoxia, or shortness of breath and arterial desaturation in the upright position with
improvement when lying down (Cheng, 2002; Murray et al., 1991), neurological decompression
illness in divers, high altitude pilots and astronauts (Fazio et al., 2010), migraine headache with
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aura, transient ischemic attacks, and obstructive sleep apneas (Appelberg, Nordahl, & Janson,
2000; Guerin et al., 2005; Ozdemir, Tamayo, Munoz, Dias, & Spence, 2008; Shanoudy et al.,
1998).
Decompression illness. Paradoxical embolism contributes to the neurological symptoms
that occur in recreational and commercial divers who develop decompression illness (Gempp,
Blatteau, Stephant, & Louge, 2009; Koch, Kirsch, Reuter, Warninghoff, & Deuschl, 2008;
Wilmshurst, Pearson, Walsh, Morrison, & Brysons, 2001). Studies have shown that divers with
PFO and decompression illness may develop significant neurologic morbidity (Moon,
Camporesi, & Kisslo, 1989). The risk of decompression illness and arterial gas embolism is 2.5
times greater in individuals with PFO (Koch et al., 2008). Further, lesions on brain imaging are
common in divers with PFO who did not develop decompression illness, with a significant
association between the severity of the RLS and number of signal abnormalities on MRI (Knauth
et al. 1997). The above findings suggest that PFO is a risk factor for brain injury and supports
the association between PFO and neurological injury.
Obstructive sleep apnea and pulmonary dysfunction. In patients with obstructive
sleep apnea, there is increased prevalence of PFO and the RLS may worsen their hypoxemia
during Valsalva maneuver (Shanoudy et al., 1998). Individuals with severe obstructive sleep
apnea have more PFO-related RLS during sleep, as observed by an increased number of
microbubbles that pass to the brain, although this does not appear to exert significant influence of
the severity of nocturnal oxygen desaturation (Lau et al., 2013). Thus, Valsalva maneuver rather
than resting state RLS, may be the mechanism that influences blood oxygenation levels.
Treatment of obstructive sleep apnea with continuous positive airway pressure successfully
decreases shunting due to PFO (Beelke et al., 2002; Pinet & Orehek, 2005).
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Notably, patients with asymptomatic PFO have decreased pulmonary gas exchange
efficiency compared to controls (no PFO), and experience more hypoxia (Lovering et al., 2011),
although this difference was not observed during exercise. Other studies have shown that one
third of patients with PFO-related stroke experience oxygen desaturation during exercise
(Devendra, Rane, & Krasuski, 2012), which improves dramatically following PFO closure. The
baseline blood oxygenation level differs between individuals with and without PFO along with
marked variability between PFO patients, which likely relates to functional outcome and may aid
in better identification of those in need of PFO closure.
Migraine. Migraine is a chronic-intermittent neurovascular disorder characterized by
severe unilateral headache of pulsating quality and a combination of gastrointestinal (nausea) and
autonomic (photophobia and phonophobia) symptoms, and in some patients, transient neurologic
dysfunction known as migraine with aura (Kurth & Diener, 2006; Sathasivam and Sathasivam,
2013). Research has demonstrated an association between migraine with aura and increased risk
for ischemic stroke (Anzola et al., 1999; Becker et al., 2007; Del Sette et al., 1998; Henrich &
Horowitz, 1989; Lamy et al., 2002). The pooled relative risk of ischemic stroke among
individuals with migraine is 2.16 (95% CI, 1.89 to 2.48); the risk of stroke for individuals with
migraine with aura is 2.27 compared to 1.83 in individuals who have migraine without aura
(Etminan, Takkouche, Isorna, & Samii, 2004).
Platelet hyperaggregability and the reduction in cerebral blood flow that may occur in
migraine with aura are thought be to potential mechanisms for migraine and stroke (Etminan et
al., 2004). Platelet hyperaggregability and reduced cerebral blood flow are likely insufficient to
cause ischemic injury (Kurth & Diener, 2006) and thus, the pathophysiology of migraine (i.e.,
vascular dysfunction) coupled with cardiovascular risk factors (i.e., PFO) likely contribute to the

11
development of stroke in individuals with migraine. For example, transient focal neurological
symptoms due to vasoconstriction occur subsequent to paradoxical embolism via RLS (Domitrz,
Mieszkowski, & Kaminska, 2007). Although PFO and migraine with aura may be independent
risk factors for stroke, the PFO-migraine relationship is less clear and research to date has been
mixed in determining the plausibility of PFO as a cause of migraine.
The estimated prevalence of individuals with PFO who experience migraine with aura is
approximately 50% (Caputi et al., 2009; Schwedt, Demaerschalk, & Dodick, 2008) and the rate
of PFO in individuals with migraine is twice that of non-migraine controls (Adami et al., 2008).
Relationships between migraine and younger age, female sex, and PFO have been reported
(Lamy et al., 2002; Post, Thijs, Herroelen, & Budts, 2004; Wilmshurst & Nightingale, 2001;).
Possible pathophysiological mechanisms for the PFO-migraine relationship include 1)
subclinical emboli (platelet hyperaggregability) and metabolites (serotonin) entering the systemic
circulation via PFO and causing irritation of the trigeminal nerve and brain vasculature, and 2)
transient hypoxemia (resting and stress) due to RLS induced microinfarcts and irritation in the
brain (Botto et al., 2007; Etminan et al., 2004; Naqvi, Rafie, & Daneshvar, 2010). Despite the
plausibility of PFO causing migraine, evidence suggests the relationship is complex, including:
1) unpredictability of embolic events in the context of lateralizing and cyclical migraine (Gupta,
2010); 2) migraine onset typically occurring in adolescence, while the PFOs are present from
birth; 3) the size of PFO increases with age and while migraine attacks typically subside with age
(Gupta et al., 2008); 4) the prevalence of migraine is two times more common in females,
alternatively PFO prevalence is equal across genders (Campbell, 1990); 5) propranolol promotes
platelet activation and aggregation, but it is effective in migraine prophylaxis (Joseph et al.,
1998); 6) migraine is more frequent in younger than older patients with stroke (Hagen et al.,
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1984); and 7) RLS is not associated with increased white matter lesion load in individuals with
migraine (Adami et al., 2008; Sathasivam & Sathasivam, 2013). Epidemiological studies
examining this relationship are mixed and the only randomized controlled trial found
improvement of migraine with PFO closure but has failed to support a causative relationship.
Benefits of Patent Foramen Ovale Closure
The conventional medical therapies for patients with stroke or TIA secondary to PFO
include long-term anticoagulation, antiplatelet medications, and surgery. Anticoagulants carry a
risk of hemorrhage, and data do not support the routine use of anticoagulants in patients with
PFO (Furlan, 2004). Recent technological advances have led to low risk, percutaneous device
and coil closure options for PFO, thereby making prevention of paradoxical embolic brain and
systemic injury feasible. Martin et al. (2002) studied the immediate and long-term clinical
effects of transcatheter PFO closure in a cohort of 110 patients. Effective occlusion of the PFO
was achieved in 100% of patients, and only two patients had recurrent neurological events due to
device misalignment or small shunt two years post-closure (Martin et al., 2002). The rate of
serious complications following percutaneous transcatheter PFO closure occurs in less than one
percent of patients (Furlan, 2004), suggesting percutaneous transcatheter PFO closure is a safe
intervention for CVA prophylaxis.
Several studies have investigated PFO closure as a mechanism to reduce or eliminate
migraine. Reisman et al. (2005) found complete resolution of migraine symptoms in 56% of
patients who underwent closure of the PFO, and 14% of patients had a significant reduction in
migraine frequency. There was an 80% reduction in the mean number of reported migraine
episodes per month following PFO closure (Reisman et al., 2005). Patients with cryptogenic
stroke had a significant and persistent decrease in the prevalence of migraine with aura six
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months after PFO closure (Post et al., 2004). Additionally, patients with migraine with aura had
a 54% reduction in the frequency of migraine attacks post PFO closure (Schwerzmann et al.
2004). These studies suggest a strong relationship between PFO and migraine with aura, and
lend credence to the benefits of PFO closure above and beyond prevention of stroke.
Diagnosis of Patent Foramen Ovale
The diagnosis of RLS relies upon the visualization of bubbles in the left atrium, which
has historically been assessed using either transesophageal echocardiography (TEE) or
transthoracic echocardiography (TTE). Power M-mode Transcranial Doppler (TCD) is a more
recent technique for RLS evaluation that is reproducible, low cost, timely (15-20 minutes), and
semi-quantitative. Transcranial Doppler has excellent concordance with TEE and studies have
found 100% sensitivity, specificity, and diagnostic accuracy for TCD compared with TEE for
detection of inter-atrial RLS (Belvis et al., 2006; Nemec et al., 1991; Sastry, Daly, Chengodu, &
McCollum, 2007). Evaluation of shunt severity, shunt duration (resting flow) and shunt
variation with postural change make TCD an optimal test for diagnosis, quantification and risk
stratification of patients with neurological conditions and RLS (Giardini et al., 2007; Jesurum et
al., 2007; Sastry et al., 2006; Spencer et al., 2004). The Spencer Logarithmic Grading Scale is a
TCD grading system used to quantify severity of RLS that has equal sensitivity but superior
specificity and diagnostic accuracy compared with other TCD grading techniques (Lao et al.,
2008), and is considered the gold standard for quantification of RLS.
Despite the benefits of using TCD to diagnose RLS, the putative effects of TCD on
cognition are unclear. While neurological symptoms have been reported in patients with larger
RLS (i.e., Spencer Grades 2-5+) during or following routine diagnostic bubble TCD (Anzola,
2009; Sorensen et al., 2010), no studies to date have evaluated cognitive outcomes using

14
standardized neuropsychological tests pre- and post-routine diagnostic bubble TCD.
Additionally, the minimal microembolic signals suggest clinically relevant RLS has not yet been
established (Jauss & Zanette, 2000).
Purpose of the Current Study
The purpose of this study was to evaluate cognitive outcomes in patients who undergo
routine diagnostic bubble contrast TCD. The aims of the study were (1) to determine if cognitive
function declined pre- to post-TCD evaluation and, (2) to assess the relationship between
cognitive function and severity of the RLS, as measured by the Spencer Grading system.
Aims and Hypotheses
The first aim is to assess the relationship between diagnostic bubble contrast TCD and
cognitive functioning. The first hypothesis is that participants undergoing diagnostic bubble
contrast TCD will experience a significant decline in cognitive functioning, irrespective of shunt
size.
The second aim is to assess the effect of shunt size on cognition following TCD. The
second hypothesis predicts that participants with a moderate-to-severe shunt will have
significantly slower reaction times and decreased attention and working memory ability
following TCD compared to the participants with little to no shunting.
Method
Participants
Individuals referred to Sorensen Cardiovascular Group for diagnostic Power M-mode
TCD for the presumed diagnosis of RLS were evaluated for the study. Study inclusion criteria
were age ≥ 18 and < 60 years and undergoing diagnostic TCD as part of their routine clinical
care. Study exclusion criteria were prior cognitive impairment that prevented the subject from
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living independently at study enrollment (e.g., mental illness requiring institutionalization,
acquired or congenital mental retardation, traumatic brain injury, stroke with severe cognitive
deficits, Parkinson’s disease, Huntington’s disease, dementia), pregnancy, atrial septal aneurysm,
or prior cardiac surgery. This study had IRB approval and informed consent was obtained from
all participants prior to their participation in the study.
Procedures
Two independent review boards, Western Institutional Review Board and the institutional
review board at Brigham Young University, approved the study protocol. All data was collected
and de-identified at Sorensen Cardiovascular Group, Murray, UT on all participants who had
provided written informed consent. Participant demographic and medical information was
collected prior to cognitive evaluation and Power M-mode TCD testing. Demographic and
medical information was collected by questionnaire and included age, education, ethnicity, sex,
prior psychiatric diagnosis of depression or anxiety, and medications. Patients were also
administered a brief headache questionnaire and cognitive tests.
Measures
Cognitive testing. Participants completed an eight minute computerized CogState
battery to assess cognitive function. The CogState computerized battery was designed to
detect the presence or absence of cognitive change when performance is repeatedly measured
over short retest intervals (Maruff et al., 2008). The CogState uses computer-administered
stimuli in the form of standard playing cards that are familiar to most cultures and education
levels and measure a wide range of cognitive function (e.g., psychomotor speed, reaction time,
working memory, attention). The CogState allows for nearly unlimited combinations (i.e.,
alternate forms) of item presentation in a random order, as well as an extensive range of
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continuous data (Collie et al., 2005; Falleti, Maruff, Collie, Darby, & McStephen, 2003; Maruff,
2005). CogState data metric properties that aid in detecting cognitive change in individuals
include interval level outcome data, lack of range restrictions, and normal distributions (Collie,
Maruff, Darby, & McStephen, 2003b; Mollica, Maruff, & Vance, 2004; Snyder et al., 2005a).
The tests have good reliability (test-retest between .84 to .91 at 10 minutes) and validity (Collie
et al., 2003a; Maruff, 2005), as well as good sensitivity and specificity for detecting even mild
cognitive impairment (Cysque, Maruff, Darbie, & Brew, 2006; Darby et al., 2004).
The construct validity of the CogState is demonstrated by its significant association
with comparator neuropsychological tests (Maruff et al., 2009). Measures specific to this study,
psychomotor speed, attention, and working memory, correlate well (r=.78-.81) with established
neuropsychological measures (Maruff et al., 2009). Cogstate subtests selected from the overall
battery were chosen due to their measurement of domains that are sensitive to brain injury,
including processing speed (Caine & Watson, 2000), working memory, and attention (Armengol,
2000).
Due to observed practice effects between the first and second administrations of each test,
a dual baseline is recommended. Practice effects are stabilized subsequent to the second
administration and test performance remains stable at retest intervals of 10 minutes to one week
(Faletti, Maruff, Collie & Darby, 2006). The Cogstate battery was administered initially after
which the battery was immediately administered a second time to obtain their baseline test (using
alternate forms). Participants then underwent clinical diagnostic bubble TCD procedure
(described above), done by trained cardiology technicians under the supervision of a physician.
Immediately following TCD (within five minutes), participants were administered the post-test
using the same eight minute computerized CogState test battery, using alternate forms.
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Three tests from the CogState battery were administered: the Detection Task
(psychomotor function and speed of processing, test time = two minutes), Identification Task
(visual attention and vigilance, test time = two minutes), and the Two Back Task (working
memory, test time = two minutes). The total time for the pre-test was 16 minutes (one practice
and one baseline test) and eight minutes for the post-test administration. Laptop computers were
used to run the CogState battery using the Windows XP operating system.
At the beginning of each task, written instructions were presented on the screen and the
task instructions were read aloud to each participant. Each task requires selection of a Yes or No
response using the right and left mouse pad keys on the laptop track board. The buttons were
labeled “Yes” and “No” and each participant was given an active demonstration and about one
minute to familiarize them with the buttons prior to the administration of the test battery.
The Detection task is a simple reaction time test in which the participant must attend to
the task in the center of the screen and select the Yes key following the rule “Has the card turned
face up?” The task continued until the two-minute time limit had elapsed. The primary outcome
measure is speed of correct responses in milliseconds. The Identification Task is a choice
reaction time task in which the participant must attend to the card in the center of the screen and
select either “Yes” or “No” following the prompt “Is the face-up card red?” The task was
continued until the two-minute time limit has elapsed. The primary outcome measure is the
speed of correct responses in milliseconds. The Two-Back task (Figure 7) requires the
participant to attend to the card in the center of the screen and respond according to the rule “Is
this card the same as the card shown before the previous card? In other words, is the card two
cards back the same as the one currently presented?” The task continued until the two-minute
time period has elapsed. The primary outcome measure is accuracy of performance, or the
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number of correct responses (percent correct of the total trials). After participants completed the
post-test cognitive battery, their participation in the study was complete.
Headache. Diagnosis of migraine was made using the International Headache Society’s
structured migraine history questionnaire. Diagnostic criteria includes the following: A) at least
two headache attacks lasting four to 72 hours (untreated or successfully treated), B) migraine
aura that occurs with criterion A, and includes at least two of the following characteristics:
unilateral location, pulsating quality, moderate or severe pain intensity, aggravation by or
causing avoidance of routine physical activity, and C) not attributable to another disorder
(Olesen, 2005). Patients were also asked if their physician had previously diagnosed them with
migraine or migraine with aura. Patients with physician-diagnosed migraine and/or participants
who meet diagnostic criteria according to the IHS Headache Classification Subcommittee
(migraine questionnaire) were considered as having active migraine.
Depression and anxiety. Participants were asked whether or not they had a formal
diagnosis of depression or anxiety made by either a physician or psychiatrist.
Bubble-contrast transcranial doppler evaluation. Clinical Power M-mode TCD was
performed as previously described (Spencer et al., 2004). All TCD studies were done as part of
the patient’s routine clinical care by medical personnel. TCD is widely used to evaluate intracranial blood flow. Power M-mode TCD is a newer application of this technology to evaluate
right-to left shunting through intra-cranial bubble detection that displays the power and the
velocity/frequency of the Doppler signal. Bilateral middle cerebral arteries were located using a
hand-held 2-megahertz probe prior to affixing bilateral 2-megahertz ball probes using a secure
head frame (Spencer Technologies).
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Transducers were adjusted by angulation and depth control (60-70 mm usually) and
minimal (ALARA) power to obtain optimal power M-mode windows, representing flow in the
middle and anterior cerebral arteries, and spectrogram windows, representing the blood velocity
profile of the selected power M-mode depth (Figure 3). Imaging was performed using a PM-100
(Spencer Vascular, Seattle, Washington) in the resting state and after contrast injection at rest
and with calibrated respiratory strain. Insonation was performed with 33 gates placed at 2 mm
intervals along the ultrasound beam permitting selection of gate depth for the spectral analysis.
The middle cerebral artery was used for bilateral spectral analysis. Contrast injection was
performed following rapid mixing of 8 cc of bacteriostatic saline, ½ cc of withdrawn blood, and
½ cc of air using two syringes and a stopcock with a minimum of 10 agitations. Calibrated strain
(valsalva maneuver) utilized a mouthpiece connected directly to a dial manometer viewed by the
patient with strain calibrated to 40 mm mercury pressure.
Cerebral microembolic events were quantified by an automatic embolic detection
program (Spencer Vascular Laboratories) that separates artifact from embolic events and counts
emboli (micro-bubbles) at depths of 30 mm to 81 mm. This technique results in emboli that
appear as brightly colored embolic events in the arteries. Embolic events (micro-bubbles) also
appear on the spectrogram as embolic signals (Figure 3). All data was recorded continuously
and saved for visual review and confirmation using the automated detection system.
Calibrated respiratory strain RLS was graded using the Spencer Logarithmic Grading
Scale. The scale is as follows:
Grade 0:

No embolic events.

Grade 1:

1-10 cerebral embolic events.

Grade 2:

11-30 cerebral embolic events.
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Grade 3:

31-100 cerebral embolic events

Grade 4:

101-300 cerebral embolic events.

Grade 5:

Greater than 300 countable discrete events.

Grade 5+: Overwhelming events (so called “curtain” effect).
The number of embolic events represents the detection of bubble conductance by RLS to
the middle cerebral arteries. The conductance is the result of intra-cranial arterial distribution,
the size of the intra-cardiac defect (ASD, PFO, p-AVM) while permitting flow, right-to-left
pressure gradient of the defect, and the duration of flow. Grades 0 to 1 indicate no shunt, Grades
2 and 3 indicate moderate shunt, and grades 4, 5, and 5+ represent severe shunt based upon
previous validation and definition studies (Jesurum et al., 2007; Lao et al., 2008; Sastry et al.,
2006; Spencer et al., 2004).
Statistical Analyses
Descriptive statistics were conducted for demographic, medical, psychiatric history (e.g.
depression and anxiety), and cognitive data (e.g., working memory, processing speed, and
attention), including: distributions, means, medians, variances, standard deviations, skewness,
kurtosis, ranges, and quartiles. Data were also examined for homogeneity of variance.
Continuous data are presented as means ± standard deviations (SD), while categorical variables
are presented as proportions. Continuous data was analyzed by independent samples t-tests and
categorical data by chi-square analysis; relationships between variables were analyzed with
ANOVA and its variants. All analyses were performed using SPSS version 22. All repeated
measures ANOVAs were two-tailed, where applicable, with an alpha level of .05 (α = .05).
A grouping variable was created to test hypothesis 2, that participants with a moderate-tosevere shunt will have significantly slower reaction times and decreased attention and working
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memory ability following TCD compared to the participants who have little to no shunting. The
two groups were created based upon previous validation and definition studies for shunt size and
severity; Grades 0-1 indicate no shunt, Grades 2-3 indicate moderate shunt, and Grades 4-5
indicate severe shunt (Jesurum et al., 2007; Lao et al., 2008; Sastry et al., 2006; Spencer et al.,
2004), as well as on the distribution of the sample. Spencer grades 3-5 are highly sensitive and
specific in predicting whether a functional PFO is present and whether it can be determined with
catheterization (Lao et al., 2008).
Data were screened for missing data and violations of assumptions of parametric
statistical analyses, including outliers, non-normality, non-linearity, and heteroscedasticity.
Notably, data had not been previously corrected for age or education. One participant had
missing baseline data for all cognitive variables that was replaced with their initial test, as there
were no significant effects of practice for either the processing speed or attention variables for
the whole sample (see results below).
Outliers. All quantitative data (per shunt group per time point) were inspected for
outliers using boxplots. A few outliers were identified on some of the variables; however, none
were extreme (±3 SD; Tabachnick and Fidel, 2007). Outliers were inspected for accuracy in raw
data by verification with source documents. Outliers were considered to accurately reflect
reasonable variability in scores on each of the variables (Tabachnick and Fidel, 2007), and were
fenced using an operational definition [median ± (2 x interquartile range)] to decrease the
probability of type I and/or II errors and to improve the generalizability of the data.
Normality. Normality was assessed (per group per time point) on each of the variables.
Data was assessed visually (e.g., histograms) and statistically, using a cutoff of z = ±3 for
determining significant skewness and kurtosis (Tabachnick and Fidel, 2007). Two kurtotic
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distributions (working memory baseline for the no-shunt group z = 3.705 and processing speed
post-test for the shunt group z = 3.267) and two skewed distributions were identified (processing
speed baseline for the shunt group z =3.643; processing speed posttest for the shunt group z
=3.347), even after outliers were fenced. Data transformations appropriate for moderate positive
skewness (square root, log10, natural log) were applied, with no effect on the skewness or
kurtosis of the data, likely due to the fact that the data were previously log10 transformed. Nontransformed data (original log10 transformed data) were used due to the mild nature of nonnormality and failure of transformed data to be normalized.
Hypothesis 1. To evaluate whether patients undergoing diagnostic bubble contrast TCD
had a decline in cognitive function, irrespective of shunt group membership, three separate
repeated-measures analysis of variance (ANOVAs) were performed for each of the cognitive
variables (processing speed, attention and working memory), with two time points, pre-TCD
(baseline) and post-TCD (post-test), as the within-subjects factor and no grouping factor in the
model. Covariates included in the model were age, education, and practice effects for working
memory only.
Hypothesis 2. To evaluate the effect of shunt size on cognition following TCD, three
separate repeated measures ANOVAs were performed for each of the cognitive variables, with
two time points, pre-TCD (baseline) and post-TCD (post-test), as the within subjects factor and
one grouping factor of presence or absence of shunt as the between-subjects factor accounting
for covariates (age, education and practice effects for working memory).
Exploratory analyses. A practice test was administered prior to the baseline and posttest to mitigate practice effects that may occur with repeated assessment. To evaluate whether
there were practice effects for any of the three cognitive tests, three separate repeated-measures
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ANOVAs were performed with two time points, practice test and pre-TCD (baseline test), as the
within-subjects factor.
To evaluate whether demographic variables or depression or anxiety were associated
with cognitive functioning three separate repeated-measures ANOVAs were run for each of the
dependent cognitive variables, with age, education, depression, and anxiety as the betweensubjects factor.
To evaluate whether individuals with no shunting (SG = 0) differed from those with only
severe shunt (SG = 5) three separate repeated-measures ANOVAs were run for each of the
dependent cognitive variables, with two time points, pre-TCD (baseline) and post-TCD (posttest), as the within subjects factor and one grouping factor of presence or absence of shunt as the
between-subjects factor accounting for covariates (age, education, and practice effects for
working memory).
Results
One hundred and five participants referred to Sorensen Cardiovascular Group for
diagnostic Power-M-mode TCD for the presumed diagnosis of RLS were enrolled in the study.
One participant dropped out of the study after the practice cognitive assessment due to time
limitations needed to complete her clinical care. Therefore, 104 participants (mean age
36.8±11.3 years) who underwent diagnostic TCD for evaluation of RLS completed all cognitive
data. The sample was predominately Caucasian (n = 99), female (n = 77), highly educated (M =
14.2±2.3 years; range 8-19 years), right handed (n = 88), and had migraines (n = 98) (Table 1).
Descriptive statistics for demographic and medical data are shown in Table 1. Migraine
was diagnosed in 94% of the sample (n = 98) and migraine status did not significantly differ by
shunt group (χ2 = 0.01); individuals with migraine comprised 94% of the no shunt group and
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94% of the shunt group. Sixteen percent of participants had comorbid medical diagnoses (i.e.,
stroke, concussion, heart disease), 15% of no shunt and 18% of shunt participants had comorbid
medical diagnoses; this difference was not significant (χ2 = 0.19). Six participants were
diagnosed with a premorbid stroke or TIA, one had a history of concussion, three had multiple
sclerosis (MS), and two had heart disease. Thirty-eight percent of participants reported taking
one or more medications; 43% of the no shunt group and 32% of the shunt group; this difference
was not significant (χ2 = 3.99). Additionally, benzodiazepine (χ2 = 2.89) and antidepressant (χ2 =
0.05) prescriptions did not significantly differ by shunt group (Table 1).
For hypothesis two participants were separated into two groups based on 1) no shunt
(Grade 0-1; n = 54) and 2) moderate-to-severe shunt (Grades 2-5; n = 50), based on previous
validation studies (Lao et al., 2008) and on the distribution of the sample (n = 37 for SG = 0; n =
17 for SG = 1; n = 0 for SG = 2; n = 6 for SG = 3; n = 5 for SG = 4; and n = 39 for SG = 5).
When comparing the no shunt (SG = 0-1) and shunt (SG = 3-5) groups, there were no differences
for age, t (104) = 0.99, p = .326 or education, t (99) = 1.45, p = .150. The participants were
predominantly female with males comprising only 31% of the no shunt group and 20% of the
shunt group; this difference was not significant (χ2 = 1.78).
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Table 1. Descriptive Statistics for Demographic and Medical Variables.
Total Sample
(n = 104)
Mean ± SD

No Shunt
(n = 54)
Mean ± SD

Shunt
(n = 50)
Mean ± SD

No Shunt
vs. Shunt
t

p

Age (years)

36.8±11.3

37.8±11.4

35.7±11.1

0.99

0.33

Education (years)

14.2±2.3

14.5±2.4

13.8±2.1

1.45

0.15

Variable

n

n (% within
group)

n (% within
group)

χ2

p

Females

77

37 (69)

40 (80)

1.78

0.18

Males

27

17 (31)

10 (20)

1.78

0.18

Comorbid Conditions

17

8 (15)

9 (18)

0.19

0.66

Migraine

98

51 (94)

47 (94)

0.01

0.92

Medicated

39

23 (43)

16 (32)

3.99

0.26

Anti-Depressants

26

13 (24)

13 (26)

0.05

0.82

Anti-Psychotics

1

1 (2)

Benzodiazepines

12

9 (16)

3 (6)

2.89

0.09

Variable

Psychiatric History

χ2

p

Depression

33

18 (33)

15 (30)

0.13

0.71

Anxiety

30

19 (35)

11 (22)

2.19

0.14

Practice Effects
Data for the practice effects are shown in Table 2. When all participants were analyzed
in one group, there was no significant difference between practice and baseline for processing
speed or attention. However, there was a significant difference for working memory (p = .000,
partial η2 = .22), with participants performing more accurately at baseline (second test
administration) than on the initial test. After adjusting for education and age the practice effect
for working memory did not remain significant F (1, 104) = .12, p = .73, partial η2 =.001.
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Table 2. Practice Effects (pre-test to baseline assessment) collapsed across group.
Practice (n = 104)
Mean ± SD

Baseline (n = 104)
Mean ± SD

2.56±.079

2.57±.081

.893

Partial Eta2
0.009
.347

Attention

2.75±.079

2.75±.068

.188

.666

0.002

WM

1.21±.169

1.29 ±.164

28.6

.000

0.217

Variable
PSI

F

p

Abbreviations are as follows: PSI = processing speed; WM = working memory

Hypothesis 1
There were no main effects of time for processing speed or attention comparing baseline
to post-test scores when analyses were collapsed across shunt groups (no shunt and moderate-tosevere shunt), adjusting for age and education. There was a main effect for working memory
when comparing baseline and post-test scores, indicating significant improvement in working
memory scores from baseline to post-test even after adjusting for practice effects, age, and
education (p = .04; See Table 3). Table 3 shows change in cognitive function from baseline to
post-test.
Effect of Depression, Anxiety, Age, and Education
There was a main effect for depression (history of depression) on processing speed (p =
.01; Appendix A; Table A6). Participants diagnosed with depression had significantly slower
processing speed than individuals who did not have a diagnosis of depression, after adjusting for
age and education. No main effects of depression were observed for attention or working
memory and no interaction of depression and time was observed for any of the cognitive
variables, adjusting for practice effects, age, and education. There was no main effect of anxiety
(history of anxiety) and no interaction between anxiety and time on processing speed, attention,
or working memory, adjusting for the effects of practice, age, and education (Appendix B; B7).
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There were no main effects for gender, age, or education and there was no time by gender
or time by education interactions for any of the cognitive variables, even after adjusting for the
effects of practice. There were no time by age interaction effects for processing speed or
attention, however, there was an age by time interaction effect for working memory (p = 0.02),
adjusting for the effects of practice and education. In order to examine the interaction, age was
analyzed using a median split. The main effect of age group on working memory score, using
median split (younger and older than 35), was significant F (1, 104) = 4.82, p = 0.03, η2 of .047,
adjusting for practice effects and education. There was a significant two-way interaction, where
individuals older than 35 had improved working memory scores from baseline to post-test and
those younger than 35 had stable working memory performance across the two time points.
Hypothesis 2
Hypothesis two assessed the effect of shunt size on cognition following TCD. There was
no main effect of shunt and no significant two-way interactions of shunt group by time for
processing speed, attention, or working memory, adjusting for working memory practice effects,
age, and education (Table 4). The age by time by shunt interaction effect was not significant for
working memory, F (1,104) = 0.01, p = 0.92, η2 of .000.
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Table 3. Baseline and post-TCD test Cognition.
Baseline (n=104)
Mean ± SD

Posttest (n=104)
Mean ± SD

F

df

p

Partial Eta2

Processing Speed

2.57±.007

2.57±.007

0.47

1

0.49

0.005

Attention

2.75±.007

2.75±.008

0.05

1

0.83

0.000

Working Memory

1.29±.013

1.32±.016

4.50

1

0.04

0.044

Processing Speed

3.56

1

0.06

0.035

Attention

1.76

1

0.18

0.018

Working Memory

2.94

1

0.09

0.029

Processing Speed

0.12

1

0.73

0.001

Attention

0.85

1

0.36

0.009

Working Memory

0.20

1

0.65

0.002

Processing Speed

0.60

1

0.44

0.006

Attention

0.09

1

0.75

0.001

Working Memory

3.37

1

0.07

0.034

Processing Speed

1.59

1

0.21

0.016

Attention

0.76

1

0.38

0.008

Working Memory

6.12

1

0.02

0.059

Variable
Main Effect of Time

Main Effect of Age

Main Effect of Education

Main Effect of Gender

Age x Time Interaction

Under 35 years

1.33±.019

1.33±.024

Over 35 years

1.25±.019

1.31±.023

Education x Time Interaction
Processing Speed

0.00

1

0.98

0.000

Attention

0.14

1

0.71

0.001

Working Memory

2.12

1

0.15

0.021

Processing Speed

0.10

1

0.75

0.001

Attention

1.36

1

0.25

0.014

Working Memory

2.35

1

0.13

0.024

Gender x Time Interaction

*p < .05, two-tailed. **p < .01, two-tailed. ***p <.001, two-tailed
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Table 4. Baseline and post-TCD test Cognition by Shunt Group.
No Shunt (n = 54)
Mean ± SD

Shunt (n = 50)
Mean ± SD

F

df

p

Partial Eta2

Processing Speed

2.58±.010

2.56±.010

1.87

1

0.17

0.019

Attention

2.75±.009

2.74±.010

1.79

1

0.18

0.018

Working Memory

1.31±.019

1.30±.019

0.84

1

0.77

0.001

Baseline (n = 104)
Mean ± SD

Posttest (n = 104)
Mean ± SD

F

df

p

Partial Eta2

0.28

1

0.87

0.000

0.93

1

0.34

0.010

1.84

1

0.19

0.019

Variable
Main Effect of Shunt

Shunt x Time Interaction
Processing Speed
No Shunt

2.58±.010

2.58±.011

Shunt

2.57±.010

2.56±.011

Attention
No Shunt

2.76±.009

2.76±.011

Shunt

2.73±.009

2.74±.011

Working Memory
No Shunt

1.29±.019

1.33±.023

Shunt

1.30±.019

1.31±.023

*p < .05, two-tailed. **p < .01, two-tailed. ***p <.001, two-tailed

Alternate Shunt Groups (Spencer Grade 0 vs. 5)
An alternative shunt group was created excluding those participants with mild to
moderate shunt (Spencer Grades 1-4) to evaluate the second hypothesis in participants who
experienced no microbubbles and those with the highest microbubble load. Therefore,
participants were re-grouped according to those with no shunt (SG = 0; n = 37) and large shunt
(SG = 5; n = 39) only. Descriptive statistics for demographic and medical data for the no shunt
and large shunt groups found no difference for age, t(74) = 1.265, p = .210, or educations, t(72) =
.956, p = .343 (Table 5). The sample was predominantly female with males comprising only
35% of the no shunt group and 18% of the large shunt group; this difference was not significant
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(χ2=2.89). Consistent with findings using the original grouping method, the shunt by time
interactions for processing speed, attention, and working memory were not significant, even after
adjusting for practice effects, age, and education. Individuals with migraine accounted for 95%
of the no shunt (SG 0; n = 37) group, while 92% of patients with large shunt (SG 5; n = 39) were
diagnosed with migraine, and this difference was not statistically significant (χ2 = 0.16).

Table 5. Baseline and post-TCD test Cognition, by Alternate Shunt Group (Spencer Grade 0 and 5).
No Shunt (n = 37)
Mean ± SD

Shunt (n = 39)
Mean ± SD

F

df

p

Partial Eta2

Processing Speed

2.58±.012

2.56±.012

1.21

1

0.27

0.017

Attention

2.75±.012

2.74±.011

0.43

1

0.51

0.006

Working Memory

1.30±.024

1.30±.022

0.03

1

0.86

0.000

Baseline
Mean ± SD

Posttest
Mean ± SD

Processing Speed

2.57±.009

2.58±.010

0.11

1

0.74

0.002

Attention

2.74±.008

2.75±.009

0.06

1

0.79

0.001

Working Memory

1.29±.016

1.31±.019

2.05

1

0.16

0.029

Processing Speed

0.09

1

0.76

0.001

Attention

0.04

1

0.83

0.001

Working Memory

1.30

1

0.26

0.019

Variable
Main Effect of Shunt

Main Effect of Time

Shunt x Time Interaction

Migraine

n (% within group)

n (% within group)

χ2

35 (95)

36 (92)

0.16
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Discussion
The current study assessed the effects of diagnostic bubble contrast TCD on cognitive
function in participants with and without a PFO. We found a high prevalence of large shunt
(38%) in our sample, which is higher than the estimated incidence of 2.4-4.9% of large PFO size
in the general population (Hagen et al., 1984; Wilmshurst et al., 2001). The high prevalence of
large RLS in our sample may reflect the pre-selection of patients visiting this office due to
significant cryptogenic neurological events, and severity of shunt is consistent with the high rates
of migraine headache among these individuals (94% in the current sample).
Practice Effects
Practice effects were found for working memory (small effect size) but not for processing
speed or attention tasks. However, practice effects for working memory did not remain
significant after controlling for the effects of age and education suggesting that years of
education may, in part, account for improvements from practice to baseline. Research conducted
using the CogState® battery has demonstrated variability in the effects of practice across each
task, which may depend on sample characteristics, such as medical or psychiatric disorders. The
mean education level of our participants was 14 years, which is higher than previous
investigations. Collie et al. (2003) found in neurologically normal individuals (mean education
level of 13.1 years) the positive effects of practice on simple reaction time tasks (SRT) were
most evident between the first and second administrations. Although stable performance was
achieved after the second, third, and fourth SRT assessments within a 15-minute time period, no
significant improvements in performance were observed after the second administration for the
SRT test. This is not consistent with our findings, as participants did not demonstrate practice
effects for attention or processing speed after the first assessment. Differences in our findings
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compared to Collie et al. (2003) may be related to age, as participants in Collie and colleagues’
study mean age was 63.7 years, while our sample was younger, with a mean age of 36.8 years. It
may be that older individuals benefit more from practice, at least on some CogState® tests, than
younger adults, as previous research has shown that aging results in declines in processing speed
(Burgmans et al., 2011). Consistent with our findings, however, Pietrzak, Snyder, and Maruff
(2010) found that individuals with schizophrenia (mean age 40 years; mean education level 10
years) showed no evidence of improvement in scores with repeated assessment on a SRT
measure. Taken together, the above findings support the proposition that age may play a role in
practice effects for simple reaction time tasks.
On an executive functioning task (Grotton Maze Learning Task), significant and large
practice effects (d = 2.05) were observed across four practice sessions (Pietrzak et al., 2010),
suggesting that more difficult tasks may elicit significant practice effects even in younger
cohorts. This is consistent with our findings of practice effects on a working memory test. One
potential explanation for the improvement from practice to baseline for working memory is task
difficulty and demand. Attention and processing speed tasks are simple, have few rules, and
require less mental effort than working memory tasks. The Two-Back working memory task
requires a participant to hold multiple pieces of information (card number, color, and suit) in
short-term memory in the correct sequence (two cards back), and to discriminate between novel
and previously learned stimuli. Anecdotally, participants in our study reported more difficulty
learning the Two-Back working memory task suggesting that rule acquisition instead of simple
rule implementation may in part account for these effects (Pietrzak et al., 2008; Snyder et al.,
2008). After controlling for age and education, working memory practice effects were not
significant suggesting that academic achievement had some impact on working memory.
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Pietrzak et al. (2010)’s sample was less educated (mean of 10 years of education) compared to
14 years in our sample, suggesting that these effects may reflect differences in education level
and task. This is consistent with research that demonstrates a significant effect of education on
CogState® task performance; although the effect of education was found on speeded and choice
reaction time tasks (Lim et al., 2012).
The findings of the current study provide additional support for the stability of the
Cogstate detection and identification tasks at multiple test-retest intervals within a very brief
period of time (30 minutes for 3 trials) in middle-aged, predominately Caucasian, highly
educated adults. Practice effects were observed for the Two-Back task, and age and education
level were shown to influence working memory on this test.
Hypothesis 1
There was no change in attention or processing speed abilities from baseline to post-test,
suggesting that irrespective of shunt size, participants’ attention and processing speed ability
were unaffected by the TCD procedure. The putative effects of TCD on cognition are thought to
depend on the presence of microemboli passing to the brain and causing ischemia or hypoxia,
which may produce a decline in cognitive ability. Thus, when participants with no shunt and
moderate-to-severe shunts were analyzed together cognition did not decline following the TCD
procedure, as only about 50% of participants had microbubbles passing to the brain.
Participants’ working memory ability improved from baseline to post-test, adjusting for practice
effects, age, and education. Although this effect was small to medium in size (partial η2 of 0.44),
it suggests that the positive effects of practice for working memory persisted at the third (posttest) assessment, above and beyond the initial improvement from practice to baseline.
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There were no main effects of age, education, or gender on processing speed, working
memory, or attention, when collapsed across group. Null findings of age on the three cognitive
tests may be due to the younger age of our sample (mean age of 36.8 years; range 18-60), as
prominent declines in cognitive function begin around sixth decade of life (Salthouse, 2009).
Although an age by time interaction effect was observed on working memory, those participants
older than 35 years working memory improved from baseline to post-test, while individuals
younger than 35 years working memory performance did not change over time. Thus, age did
not have a deleterious effect on executive performance in our relatively young sample. Gender
differences in cognitive ability have not been demonstrated for speed or accuracy of performance
across CogState® tasks, including Detection (processing speed), Identification (Attention), and
One-Back (working memory) tasks (Lim et al., 2012), consistent with the current findings.
Hypothesis 2
Unexpectedly, the presence of moderate to severe shunt did not result in a decline from
baseline to post-test for processing speed, attention, or working memory compared to the no
shunt group, although this study’s power to detect a difference was low. Cohen (1988) suggests
that a power of 0.80 is considered acceptable. Power calculations for a 2x1 Factorial ANOVA
indicate that for a small effect size (.25), observed power would have to be 0.39 with a sample
size of n= 90 per group. Although the sample size in the current study was relatively large (n=
104), only half those patients were included in the moderate-to-severe shunt group, suggesting
that the effect of microbubbles on cognitive function, if it exists, must be small and require at
least double the number of participants with large and no shunt in order to detect an effect.
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Alternate Shunt Groups (Spencer Grade 0 vs. 5)
In order to explore whether previously described methods for grouping PFO into no shunt
(SG = 0-1) vs. moderate-to-severe shunt (SG = 3-5) (Lao et al, 2008) were obscuring findings we
compared participants who had no shunt (SG = 0) to severe shunt (SG = 5). Findings were
consistent with the initial results, suggesting that even in patients with the largest shunt (SG 5),
who experience between 300-500 embolic events during TCD, processing speed, attention, and
working memory ability did not decline post-TCD. Thus, TCD appears to demonstrate no
immediate effect for individuals who undergo TCD testing whether or not they have a shunt, at
least in these domains of cognition and as measured by CogState® tests. However, due to the
low power these results should be interpreted with caution, as it is possible that increased power
to detect change in cognition may yield a significant effect.
Literature describing the link between cognitive functioning and microembolic load in
patients undergoing cardiac surgery has been mixed. Of 15 studies that evaluated the association
between TCD-detected microemboli and neuropsychological outcome, only five studies found a
relationship between high-intensity transient signals (HITS) and cognitive impairments (Kruis,
Vlasveld, & Van Dijk, 2010). In most studies, the correlation between microemboli and
cognitive dysfunction was observed one week post-surgery and did not persist over time,
occurred in only one cognitive domain, in a small subgroup, and often did not reflect the large
percentages of patients that improved from pre to post-test (Kruis et al., 2010). Across these
studies, cognitive dysfunction was present in patients who experienced a high microembolic load
during the procedure (greater than 500) and occurred in the domains of memory, attention,
processing speed, and motor functioning (Fearn et al., 2001; Pugsley et al. 1994). In ten studies,
no association was found between emboli and cognitive impairment. Thus, in more severe
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medical patients, such as those undergoing coronary artery bypass surgery, there are mixed
findings regarding the effect of microemboli on cognition. Indeed, some studies indicate that
cognitive impairments are present only in subtypes of cardiac patients (e.g., valve replacement)
with microembolisation (Braekken, Reinvang, Russel, Brucher, & Svennevig, 1998). This is
consistent with findings demonstrating neurological symptoms following TCD or Valsalva-like
activity, such as hemiparesis and transient ischemic attack, in patients who have multiple
additional vascular (stenosis), cardiologic (ASA), and embolic risks (Anzola, 2002; Khaffaf,
Karnik, Winkler, Valentin, & Slany, 1994; Sander et al., 2000). Overall, the preponderance of
studies suggests that microemboli are not neuropsychologically significant in high-risk cardiac
surgery patients. This is consistent with the lack of association between TCD-induced
microemboli and cognition in the current sample of young and relatively healthy patients who
have a PFO.
Other putative reasons for the null findings include time between TCD and post-test
(approximately 5-10 minutes), TCD related measurement error, and the possibility of missed
cognitive or neurological effects associated with the TCD procedure, which may be identified
using neuroimaging, neurologic examination, or other standardized neuropsychological tests. It
is possible that brief and transient cognitive effects occurred either during or immediately after
(i.e., within a few minutes) the TCD procedure and that cognitive assessment at earlier or the
cognitive effects may not appear until later time points, which were not assessed in this study.
The lack of cognitive decline at 5-10 minutes post-TCD test suggests that if cognitive deficits are
present immediately following TCD testing, they are transient and resolve quickly.
Alternatively, it may take time for neuronal injury to occur after microemboli. One study has
demonstrated an effect of microbubbles on cognition at one week following TCD (Kruis,
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Vlasveld, & Van Dijk, 2010), thus it is possible that the effects of microembolisation may not
produce cognitive deficits for days to weeks following TCD. Sorensen et al., (2010) described
self-reported neurological symptoms (e.g., loss of vision, hemi-sensory weakness,
vertigo/imbalance, migraine, or aura) in one fifth (21%) of their sample (n = 455) of post-TCD
shunt patients. Although symptoms occurred during and immediately following TCD in this
study (within 30 minutes) (Sorensen et al., 2010), the authors did not assess cognitive function.
The authors reported that those with induction of headache had symptoms that persisted after
they left the office, but that no permanent effects were observed. A timeline for resolution of the
observed neurological symptoms was not provided. It is possible that patients experiencing
neurological symptoms do not have concomitant cognitive changes, that cognitive deficits are
present only in a select sub-set of patients, and/or that effects may be observed at follow-up.
It is also possible that the cognitive domains assessed or neuropsychological tests used in
the present study were not sensitive to the effects of neuronal damage due to transient hypoxia.
One study evaluating a variety of cognitive domains, including attention, short-term recall,
comprehension, and visuoconstruction, failed to detect any effect of TCD microembolisation on
cognition. Ferrari et al. (2004) found that during transcatheter closure of PFO in patients under
65 with cryptogenic ischemic stroke, the highest rates of cerebral microembolism did not result
in neurological or cognitive deficits. Additionally, the CogState® measures used in the current
study correlate well (r = .78-.81) with established neuropsychological measures, such as Digit
Span and Trail Making Test B (Maruff et al., 2009). These findings make it unlikely that an
effect would be detected in other cognitive domains or by using gold standard
neuropsychological measures. However, alternative domains of cognition, such as executive and
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motor functioning, should be assessed in order to rule out the possibility that a lack of task
complexity may contribute to the current findings.
Another reason for the lack of microembolic effect in shunt patients may include an
insufficient degree of hypoxia necessary to induce pathophysiological dysfunction, as bubbles
are microscopic 26.7± 7.4μ and have half-lives estimated at 4.6 seconds (Jeon et al., 2002). It is
possible that microembolisation disrupts blood flow but does not altogether occlude the passage
of blood through the arteries and that bubbles are present for a short duration of time prior to
dissolution of the air and saline mixture. Therefore, such minor disruptions in flow are unlikely
to reach levels necessary for ischemic polarization (18 mL/100g of brain tissue per minute; CBF
reductions of 40-45% of normal values) and neuroinflammation (Welch & Barkley, 1986).
Individual variability in vascular health, PFO characteristics, and/or neurovascular
protective factors may also influence the effect of TCD on cognition. Medically complex
patients and those with continuous RLS (PFO and ASA) have increased frequency of multiple
ischemic lesions on MRI, previous stroke history and embolism, and more frequent migraine
than those with Valsalva-induced shunt only (Rigatelli et al., 2011). Therefore, they may
represent a subset of patients who may experience cognitive decline following TCD.
Alternatively, protective factors, such as “ischemic preconditioning,” may be present in which
transcription factors (HIF-1) activate vasculogenesis, increased glucose transport, and improved
CBF in hypoxia-prone individuals (Dirnagl, Simon, & Hallenbeck, 2003). It is possible that
individuals who have a large shunt have experienced multiple hypoxic events over the lifespan
and thus, may be less susceptible to transient hypoxemia, or that the previous events have
already resulted in cognitive decline. However, these suggestions are speculative, were not
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evaluated in the current study, and may only suggest future populations in which to evaluate the
effects of TCD on cognition.
Overall, the lack of shunt by time interaction in the current study suggests that TCDinduced microembolisation does not pose cognitive risk for individuals with even large shunt and
is consistent with studies demonstrating the general safety of TCD. Despite systematic
documentation of changes in blood pressure and heart rhythm, studies have not found adverse
events in numerous TCD bubble studies, even in patients with large PFO and concomitant ASA,
intracardiac thrombi, and cerebral ischemia (Lao et al., 2007; Lao et al. 2008; Tsvigoulis et al.,
2009; Tsvigoulis et al., 2010). Our study adds to this literature by providing additional
information about the lack of immediate cognitive effect of TCD in patients with and without
shunt.
Strengths and Limitations
To our knowledge, this was the first study to evaluate cognitive functioning in RLS
patients following TCD provocation, a procedure performed frequently as a part of routine
cardiac care. Results demonstrated the feasibility and utility of the CogState® as a brief
cognitive assessment battery in a medical setting. There were no practice effects for processing
speed and attention, thereby decreasing administration times for these tasks. Practice effects
were found for working memory at each of the three time points, although this finding may
depend, in part, on age and education variables.
Limitations of the current study include relatively small sample size (n=104) with low
power to detect an effect, limited assessment of cognitive domains (processing speed, attention,
and working memory only) and a lack of task complexity, lack an independent marker of brain
health, such as neuroimaging, and homogeneous sample restrictions, which limit generalizability
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of findings. An additional limitation is the inability in this study to follow patients in the weeks
to months after TCD to determine if there were any long-term cognitive effects.
Conclusion
Our findings suggest that TCD, administered as part of a cardiology patient’s routine
diagnostic care, does not produce any immediate cognitive effects in the domains of processing
speed, attention, or working memory, even for individuals with large RLS. Importantly, these
findings are restricted to young, relatively healthy, Caucasian individuals assessed immediately
following the TCD procedure and this finding should be replicated at other cardiac centers with
larger sample sizes at multiple time points following the bubble test.
Future Directions
Future research would benefit from assessment of a larger and more heterogeneous
sample, including inclusion of medically complex patients for study, multi-site studies, collection
of patient data related to vascular risk factors (diabetes, hypertension, hyperlipidemia), the use of
neuroimaging as an independent marker of brain injury, assessment of additional cognitive
domains, including executive functioning, and assessment of cognition at multiple time points (1
week and 1 month post-TCD).
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Appendix A
Effect of Depression on Cognition as a Function of Shunt Group and Time.
A main effect of depression on processing speed and a shunt group by depression interaction was
found on baseline attention. However, these findings become insignificant when adjusting for
multiple comparisons.
Table A6. History of Depression by Shunt Group.
Dx (n = 33)
Variable
Mean ± SD
Main Effect of Depression
Processing Speed
2.58±.012
Attention
2.76±.012
Working Memory
1.29±.024
Depression x Time Interactions
Processing Speed
Attention
Working Memory

No Dx
(n = 70)
Mean ± SD
2.56±.008
2.74±.008
1.31±.016

No Shunt
Shunt
Mean ± SD
Mean ± SD
Shunt x Depression Interactions
Processing Speed
Baseline
Depressed
2.59±.016
2.62±.018
Not Depressed
2.57±.012
2.53±.012
Posttest
Depressed
2.58±.018
2.59±.019
Not Depressed
2.57±.013
2.55±.013
Attention
Baseline
Depressed
2.75±.015
2.78±.017
Not Depressed
2.76±.011
2.71±.011
Posttest
Depressed
2.75±.018
2.77±.020
Not Depressed
2.76±.013
2.73±.013
Working Memory
Baseline
Posttest
Shunt x Depression x Time Interactions
Processing Speed
Attention
Working Memory

Partial Eta2

F

df

p

8.11
2.74
0.91

1
1
1

0.01
0.10
0.34

0.077
0.028
0.010

2.99
0.34
0.27

1
1
1

0.09
0.55
0.60

0.031
0.004
0.003

F

df

p

5.09

1

0.02

0.051

1.99

1

0.16

0.021

6.75

1

0.01

0.066

2.82

1

0.09

0.029

0.17
0.12

1
1

0.68
0.72

0.002
0.001

0.68
0.51
0.00

1
1
1

0.41
0.46
0.98

0.007
0.005
0.000

Partial Eta2
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Appendix B
Effect of Anxiety on Cognition as a Function of Shunt Group and Time.
A shunt x anxiety x time interaction was found for working memory, although this effect
becomes insignificant when correcting for multiple comparisons.
Table B7. History of Anxiety by Shunt Group.

Variable
Main Effect of Anxiety

No Shunt
(n = 54)
Mean ± SD

Processing Speed
Attention
Working Memory
Anxiety x Time Interactions
Processing Speed
Attention
Working Memory
Shunt x Anxiety Interactions
Processing Speed
Baseline
Posttest
Attention
Baseline
Posttest
Working Memory
Baseline
Posttest
Shunt x Anxiety x Time Interactions
Processing Speed
Attention
Working Memory
Baseline
Anxious
1.30±.032
Not Anxious
1.28±.039
Posttest
Anxious
1.27±.037
Not Anxious
1.36±.029

Shunt
(n = 50)
Mean ± SD

1.27±.041
1.30±.022
1.33±.049
1.30±.026

Partial Eta2

F

df

p

0.92
0.09
0.16

1
1
1

0.34
0.76
0.68

0.010
0.001
0.002

1.20
0.02
0.37

1
1
1

0.29
0.89
0.54

0.011
0.000
0.004

1.89
0.29

1
1

0.17
0.86

0.020
0.000

3.69
1.52

1
1

0.06
0.22

0.037
0.016

0.86
2.31

1
1

0.36
0.13

0.009
0.024

2.13
0.36
7.96

1
1
1

0.15
0.55
0.01

0.022
0.004
0.078
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Appendix C
Benzodiazepines and Cognition by Shunt Group.
No significant main effects or interactions were found.
Table C8. Benzodiazepines and Cognition by Shunt Group.

Variable
Gender x Shunt Interactions
Processing Speed
Attention
Working Memory

F

df

p

Partial Eta2

0.45
0.71
0.16

1
1
1

0.50
0.40
0.68

0.005
0.007
0.002

Gender x Shunt x Time Interactions
Processing Speed
Attention
Working Memory

0.01
2.68
0.05

1
1
1

0.92
0.10
0.82

0.000
0.028
0.000

0.52
1.42
0.05

1
1
1

0.47
0.23
0.81

0.005
0.015
0.001

0.39
2.25
0.12

1
1
1

0.53
0.12
0.67

0.004
0.023
0.002

No Benzo
(n = 11)
Mean ± SD
Main Effect of Benzodiazepines
Processing Speed
2.57±.007
Attention
2.75±.007
Working Memory
1.30±.014
Benzodiazepines x Time Interactions
Processing Speed
Attention
Working Memory

Benzo
(n = 90)
Mean ± SD
2.56±.021
2.73±.020
1.31±.041

